Integ. Proteins

Market Cap: Micro Cap
Industry: Edible Oil
ISIN: INE177M01013
NSEID:
BSEID: 519606

INR

36.34

0.00 (0.00%)

BSENSE

Dec 04

BSE+NSE Vol: 20

{
  "main_header": {
    "sid": 354640,
    "name": "Integ. Proteins",
    "stock_name": "Integ. Proteins",
    "full_name": "Integrated Proteins Ltd",
    "name_url": "stocks-analysis/integ-proteins",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "36.34",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "36.34",
    "mcapval": "14.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 519606,
    "symbol": "",
    "ind_name": "Edible Oil",
    "ind_code": 92,
    "indexname": "",
    "isin": "INE177M01013",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "20 ",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/integ-proteins-354640-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Integrated Proteins Faces Intense Selling Pressure Amidst Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/integrated-proteins-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3746769",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IntegratedProte_only_sellers_3746769.png",
        "date": "2025-12-04 12:41:00",
        "description": "Integrated Proteins Ltd has encountered significant selling pressure on 4 December 2025, with the stock opening sharply lower and trading exclusively at its intraday low. The absence of buyers and persistent downward momentum highlight distress selling signals, marking a challenging phase for the edible oil company amid broader market fluctuations."
      },
      {
        "title": "Is Integ. Proteins overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-integ-proteins-overvalued-or-undervalued-3734480",
        "imagepath": "",
        "date": "2025-11-28 08:07:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics Indicate Attractive Pricing</strong></p>\n<p>At a price of ₹38.25, Integ. Proteins trades with a price-to-earnings (PE) ratio of 42.6, which might appear elevated at first glance. However, this figure must be contextualised within the company’s broader valuation framework. The price-to-book (P/B) ratio stands at a notably low 0.69, suggesting the stock is trading below its book value, a classic indicator of undervaluation in asset terms.</p>\n<p>Further, the enterprise value (EV) multiples provide additional insight. The EV to EBIT and EV to EBITDA ratios both hover around 14.06, which is moderate relative to industry standards. More strikingly, the EV to sales ratio is just 0.55, indicating the market values the company at just over half its annual sales, a conservative valu..."
      },
      {
        "title": "Integrated Proteins Faces Intense Selling Pressure Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/integrated-proteins-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3733815",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IntegratedProte_only_sellers_3733815.png",
        "date": "2025-11-27 14:51:27",
        "description": "Integrated Proteins Ltd is currently experiencing extreme selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling signals a challenging phase for the edible oil company as it continues to face consecutive losses and a significant downtrend over the past year."
      },
      {
        "title": "Is Integ. Proteins overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-integ-proteins-overvalued-or-undervalued-3687525",
        "imagepath": "",
        "date": "2025-11-11 08:08:26",
        "description": "As of 10 November 2025, the valuation grade for Integ. Proteins has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, with a PE ratio of 42.60, an EV to EBIT of 14.06, and a PEG ratio of 0.11, all suggesting that the stock may be trading below its intrinsic value relative to its earnings growth potential.\n\nWhen compared to peers, Integ. Proteins stands out as attractive against Manorama Industries, which is deemed expensive with a PE of 43.52, and CIAN Agro, also expensive at a PE of 50.51. Additionally, the company's recent stock performance has been strong, with a 1-month return of 65.58%, significantly outperforming the Sensex's 1.25% return, reinforcing the notion that Integ. Proteins is undervalued in the current market landscape...."
      },
      {
        "title": "How has been the historical performance of Integ. Proteins?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-integ-proteins-3683593",
        "imagepath": "",
        "date": "2025-11-09 22:43:25",
        "description": "Answer:\nThe historical performance of Integ. Proteins shows significant growth in net sales, reaching 21.50 Cr in March 2025, up from just 0.24 Cr in March 2024 and 0.17 Cr in March 2023. The total operating income also increased to 21.50 Cr in March 2025, compared to 0.24 Cr in the previous year. The company has seen a notable rise in operating profit, which stood at 0.34 Cr in March 2025, a substantial improvement from 0.14 Cr in March 2024. Profit before tax also increased to 0.32 Cr in March 2025, up from 0.10 Cr in March 2024, while profit after tax reached 0.25 Cr, compared to 0.09 Cr in the prior year. The earnings per share (EPS) rose to 0.71 in March 2025 from 0.26 in March 2024, reflecting a positive trend in profitability.\n\nBreakdown:\nInteg. Proteins has demonstrated a remarkable upward trajectory in its financial performance over the past few years. Starting from no sales in previous years, the ..."
      },
      {
        "title": "Are Integ. Proteins latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-integ-proteins-latest-results-good-or-bad-3682479",
        "imagepath": "",
        "date": "2025-11-08 19:21:31",
        "description": "Integrated Proteins has reported its financial results for Q2 FY26, indicating a complex operational landscape. The company generated net sales of ₹4.20 crores, a notable recovery from the zero sales recorded in Q1 FY26, but significantly lower than the ₹21.49 crores achieved in Q4 FY25. This pattern of volatility raises questions about the sustainability of its recent sales resurgence.\n\nThe net profit for the quarter was ₹0.05 crores, which, while a positive figure compared to the previous quarter's loss, reflects minimal earnings for a listed entity. The operating margin stood at 2.14%, indicating very thin profitability, which is characteristic of the highly competitive edible oil processing sector. The profit after tax margin was recorded at 1.19%, further underscoring the challenges of maintaining operational efficiency and profitability.\n\nThe company has shown some improvement in return on equity (ROE..."
      },
      {
        "title": "Integrated Proteins Q2 FY26: Micro-Cap Edible Oil Processor Shows Signs of Life After Years of Dormancy",
        "link": "https://www.marketsmojo.com/news/result-analysis/integrated-proteins-q2-fy26-micro-cap-edible-oil-processor-shows-signs-of-life-after-years-of-dormancy-3680608",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IntegratedProte_quaterlyResult_3680608.png",
        "date": "2025-11-07 20:02:16",
        "description": "Integrated Proteins Limited, a Jamnagar-based edible oil processor, reported a net profit of ₹0.05 crores for Q2 FY26, marking a tentative return to operational activity after years of minimal business. The micro-cap company, with a market capitalisation of just ₹13.00 crores, recorded net sales of ₹4.20 crores during the quarter—a dramatic contrast to the near-zero revenues witnessed in preceding quarters. Despite this operational revival, the stock remains deeply troubled, down 21.92% over the past year and trading at ₹38.25 as of November 7, 2025, following a 5.00% single-day gain."
      },
      {
        "title": "Integrated Proteins Ltd Faces Significant Selling Pressure with 25.64% Yearly Loss and 51.55% Decline YTD",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/integrated-proteins-ltd-faces-significant-selling-pressure-with-2564-yearly-loss-and-5155-decline-ytd-3679651",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IntegratedProte_only_sellers_3679651.png",
        "date": "2025-11-07 11:01:29",
        "description": "Integrated Proteins Ltd is experiencing notable selling pressure, continuing a trend of losses. Despite a recent monthly increase, the stock has faced significant declines over three months and year-to-date. The erratic trading pattern and broader sector decline are contributing to negative market sentiment surrounding the company."
      },
      {
        "title": "Why is Integ. Proteins falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-integ-proteins-fallingrising-3663086",
        "imagepath": "",
        "date": "2025-10-31 23:18:14",
        "description": "As of 31-Oct, Integrated Proteins Ltd is experiencing a price increase, with the current price at Rs 36.43, reflecting a rise of Rs 1.73 or 4.99%. The stock has been on an upward trend, gaining for the last four consecutive days and achieving a remarkable 21.43% return over the past week. It opened today with a gain of 4.99% and reached an intraday high of Rs 36.43. However, the stock has shown erratic trading patterns, having not traded on two days out of the last twenty, and there has been a significant decline in investor participation, with delivery volume dropping by 95.99% against the five-day average. The stock's performance over the last month has been strong, with a 50.97% increase, although it remains down 51.55% year-to-date.\n\nIn the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has seen a slight decline of 0.32% over the past week. Whil..."
      }
    ],
    "total": 183,
    "sid": "354640",
    "stock_news_url": "https://www.marketsmojo.com/news/integrated-proteins-354640"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Nov-2025",
      "details": "Copy of the newspaper publication of the unaudited standalone financial results of the quarter and half year ended 30th September 2025 is attached",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 And 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI LODR).",
      "datetime": "07-Nov-2025",
      "details": "Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) and in continuation to our letter dated 04th November 2025 we hereby report the outcome of the meeting of the Board of Directors held today i.e. Friday 07th November 2025 inter-alia to consider and approve the following: 1. Considered and approved the unaudited financial results for the quarter ended 30th September 2025 together with the Limited Review Report by the Auditors.",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Board Meeting Pursuant To Regulation 30 And 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI LODR).",
      "datetime": "07-Nov-2025",
      "details": "Approval of Unaudited results for the quarter and half year ender 30th September 2025 for the FY 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Integrated Proteins Faces Intense Selling Pressure Amidst Consecutive Losses

2025-12-04 12:41:00

Integrated Proteins Ltd has encountered significant selling pressure on 4 December 2025, with the stock opening sharply lower and trading exclusively at its intraday low. The absence of buyers and persistent downward momentum highlight distress selling signals, marking a challenging phase for the edible oil company amid broader market fluctuations.

Is Integ. Proteins overvalued or undervalued?

2025-11-28 08:07:55

Valuation Metrics Indicate Attractive Pricing

At a price of ₹38.25, Integ. Proteins trades with a price-to-earnings (PE) ratio of 42.6, which might appear elevated at first glance. However, this figure must be contextualised within the company’s broader valuation framework. The price-to-book (P/B) ratio stands at a notably low 0.69, suggesting the stock is trading below its book value, a classic indicator of undervaluation in asset terms.

Further, the enterprise value (EV) multiples provide additional insight. The EV to EBIT and EV to EBITDA ratios both hover around 14.06, which is moderate relative to industry standards. More strikingly, the EV to sales ratio is just 0.55, indicating the market values the company at just over half its annual sales, a conservative valu...

Integrated Proteins Faces Intense Selling Pressure Amidst Prolonged Downtrend

2025-11-27 14:51:27

Integrated Proteins Ltd is currently experiencing extreme selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling signals a challenging phase for the edible oil company as it continues to face consecutive losses and a significant downtrend over the past year.

Is Integ. Proteins overvalued or undervalued?

2025-11-11 08:08:26

As of 10 November 2025, the valuation grade for Integ. Proteins has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, with a PE ratio of 42.60, an EV to EBIT of 14.06, and a PEG ratio of 0.11, all suggesting that the stock may be trading below its intrinsic value relative to its earnings growth potential. When compared to peers, Integ. Proteins stands out as attractive against Manorama Industries, which is deemed expensive with a PE of 43.52, and CIAN Agro, also expensive at a PE of 50.51. Additionally, the company's recent stock performance has been strong, with a 1-month return of 65.58%, significantly outperforming the Sensex's 1.25% return, reinforcing the notion that Integ. Proteins is undervalued in the current market landscape....

How has been the historical performance of Integ. Proteins?

2025-11-09 22:43:25

Answer: The historical performance of Integ. Proteins shows significant growth in net sales, reaching 21.50 Cr in March 2025, up from just 0.24 Cr in March 2024 and 0.17 Cr in March 2023. The total operating income also increased to 21.50 Cr in March 2025, compared to 0.24 Cr in the previous year. The company has seen a notable rise in operating profit, which stood at 0.34 Cr in March 2025, a substantial improvement from 0.14 Cr in March 2024. Profit before tax also increased to 0.32 Cr in March 2025, up from 0.10 Cr in March 2024, while profit after tax reached 0.25 Cr, compared to 0.09 Cr in the prior year. The earnings per share (EPS) rose to 0.71 in March 2025 from 0.26 in March 2024, reflecting a positive trend in profitability. Breakdown: Integ. Proteins has demonstrated a remarkable upward trajectory in its financial performance over the past few years. Starting from no sales in previous years, the ...

Are Integ. Proteins latest results good or bad?

2025-11-08 19:21:31

Integrated Proteins has reported its financial results for Q2 FY26, indicating a complex operational landscape. The company generated net sales of ₹4.20 crores, a notable recovery from the zero sales recorded in Q1 FY26, but significantly lower than the ₹21.49 crores achieved in Q4 FY25. This pattern of volatility raises questions about the sustainability of its recent sales resurgence. The net profit for the quarter was ₹0.05 crores, which, while a positive figure compared to the previous quarter's loss, reflects minimal earnings for a listed entity. The operating margin stood at 2.14%, indicating very thin profitability, which is characteristic of the highly competitive edible oil processing sector. The profit after tax margin was recorded at 1.19%, further underscoring the challenges of maintaining operational efficiency and profitability. The company has shown some improvement in return on equity (ROE...

Integrated Proteins Q2 FY26: Micro-Cap Edible Oil Processor Shows Signs of Life After Years of Dormancy

2025-11-07 20:02:16

Integrated Proteins Limited, a Jamnagar-based edible oil processor, reported a net profit of ₹0.05 crores for Q2 FY26, marking a tentative return to operational activity after years of minimal business. The micro-cap company, with a market capitalisation of just ₹13.00 crores, recorded net sales of ₹4.20 crores during the quarter—a dramatic contrast to the near-zero revenues witnessed in preceding quarters. Despite this operational revival, the stock remains deeply troubled, down 21.92% over the past year and trading at ₹38.25 as of November 7, 2025, following a 5.00% single-day gain.

Integrated Proteins Ltd Faces Significant Selling Pressure with 25.64% Yearly Loss and 51.55% Decline YTD

2025-11-07 11:01:29

Integrated Proteins Ltd is experiencing notable selling pressure, continuing a trend of losses. Despite a recent monthly increase, the stock has faced significant declines over three months and year-to-date. The erratic trading pattern and broader sector decline are contributing to negative market sentiment surrounding the company.

Why is Integ. Proteins falling/rising?

2025-10-31 23:18:14

As of 31-Oct, Integrated Proteins Ltd is experiencing a price increase, with the current price at Rs 36.43, reflecting a rise of Rs 1.73 or 4.99%. The stock has been on an upward trend, gaining for the last four consecutive days and achieving a remarkable 21.43% return over the past week. It opened today with a gain of 4.99% and reached an intraday high of Rs 36.43. However, the stock has shown erratic trading patterns, having not traded on two days out of the last twenty, and there has been a significant decline in investor participation, with delivery volume dropping by 95.99% against the five-day average. The stock's performance over the last month has been strong, with a 50.97% increase, although it remains down 51.55% year-to-date. In the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has seen a slight decline of 0.32% over the past week. Whil...

View All News

Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication

08-Nov-2025 | Source : BSE

Copy of the newspaper publication of the unaudited standalone financial results of the quarter and half year ended 30th September 2025 is attached

Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 And 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI LODR).

07-Nov-2025 | Source : BSE

Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) and in continuation to our letter dated 04th November 2025 we hereby report the outcome of the meeting of the Board of Directors held today i.e. Friday 07th November 2025 inter-alia to consider and approve the following: 1. Considered and approved the unaudited financial results for the quarter ended 30th September 2025 together with the Limited Review Report by the Auditors.